Wilson Sonsini Goodrich & Rosati advised Netflix on the transaction, and Davis Polk & Wardwell advised the underwriters. Netflix, Inc. (Nasdaq: NFLX) completed its inaugural investment...
Netflix’s $1.8 Billion Senior Unsecured Notes Offering
MKS Instruments’ $1.4 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
GTCR’s $2.7 Billion Acquisition of AssetMark
Kirkland & Ellis and Paul Hastings advised GTCR on the transaction, and Davis Polk & Wardwell advised AssetMark. GTCR, a leading private equity firm with substantial...
iRhythm Technologies’ $661.25 Million Convertible Senior Notes Offering
Fenwick & West advised iRhythm Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the initial purchasers. iRhythm Technologies, Inc. (Nasdaq: IRTC) announced its...
Cisco Systems’ $13.5 Billion Senior Notes Offering
Simpson Thacher & Bartlett advised Cisco Systems, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the underwriters. Cisco Systems, Inc. (Nasdaq:...
Intel’s $2.55 Billion Senior Notes Offering
Gibson, Dunn & Crutcher advised Intel Corporation on the offering, and Davis Polk & Wardwell advised the joint book-running managers. Intel Corporation (Intel) (Nasdaq:INTC) announced its $2.55...
Xponential Fitness’ $37 Million Incremental Senior Secured Term Loan Facility
Davis Polk & Wardwell advised Xponential Fitness, as borrower, on the deal. Xponential Fitness, Inc. (NYSE: XPOF), as borrower, in connection with a $37 million incremental...
Tenaya Therapeutics’ $50 Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
IDEAYA Biosciences’ $350 Million At-the-Market Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
Alector’s $75 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
Olema Pharmaceuticals’ $150 Million At-the-Market Offering
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
Credo’s $201.3 Million Follow-On Offering
Davis Polk & Wardwell, Maples and Calder and JunHe advised Credo Technology Group Holding Ltd on the offering. Credo Technology Group Holding Ltd (Nasdaq: CRDO) (“Credo”) announced...